Searched for
DESH BANDHU GUPTA
Sell Lupin, target Rs 875: Dr CK NarayanSell Lupin Ltd. at a price target of Rs 875.0 and a stoploss at Rs 895 from entry point.30 Aug, 2018, 09.07 AM IST- Buy Lupin, target Rs 905: Dr CK NarayanBuy Lupin Ltd. at a price target of Rs 905.0 and a stoploss at Rs 880 from entry point.23 Aug, 2018, 08.56 AM IST
- Buy Lupin, target Rs 834: Kunal BothraBuy Lupin Ltd. at a price target of Rs 834 and a stop loss at Rs 795 from entry point.11 Jun, 2018, 08.47 AM IST
- Buy Lupin, target Rs 815: Shrikant ChouhanBuy Lupin Ltd. at a price target of Rs 815.0 and a stop loss at Rs 775 from entry point.06 Apr, 2018, 08.12 AM IST
- Buy Lupin, target Rs 960: Vikas JainBuy Lupin Ltd. at a price target of Rs 960.0 and a stop loss at Rs 812 from entry point.18 Dec, 2017, 08.31 AM IST
- Buy Lupin, target Rs 880: Gaurav BissaBuy Lupin at a price target of Rs 880 and a stop loss at Rs 820 from entry point.12 Dec, 2017, 07.54 AM IST
- Lupin gets shareholders nod to raise up to Rs 7,500 croreIn a BSE filing, Lupin said shareholders have approved a proposal today "to raise funds for an amount not exceeding Rs 7,500 crore through ...25 Jul, 2015, 05.54 PM IST
- Lupin shares fall over 3% on disappointing Q4 earningsThe stock ended 3.35 per cent lower at Rs 1,690.60 on the BSE. During the day, it slipped 3.95 per cent to Rs 1,680.13 May, 2015, 07.20 PM IST
- Lupin Q4 profit falls 1% to Rs 547 croreLupin reported over 1 per cent decline in consolidated net profit to Rs 547 crore for the fourth quarter ended March 31, hit by price erosi...13 May, 2015, 05.34 PM IST
- India's rich list: Top wealth gainers & losers in last 5-7 yearsThe most notable change has been Sun Pharma's Dilip Shanghvi pipping Mukesh Ambani. The list has seen many additions and deletions.20 Apr, 2015, 09.01 AM IST
- Lupin eyes 3-fold hike in revenues to $5 billion by 2018Drug major Lupin is eyeing a nearly three-fold increase in its revenues at $5 billion by 2018 as it looks to grow its business organically.14 Jul, 2013, 12.51 PM IST
- No plans to sell India business, to be $3 bn company by FY14: LupinWhile assuring the shareholders that it had no plans to sell its India business, drug firm Lupin today said it aims to be a $3-billion firm...27 Jul, 2011, 08.47 PM IST
- Lupin acquires majority stake in South African marketing coDrug firm Lupin today said it has acquired a majority stake in a South African marketing company for an undisclosed sum marking its entry i...18 Sep, 2008, 07.23 PM IST
- Lupin acquires pharma business of RubaminDrug maker Lupin Ltd on Thursday said it has acquired the pharmaceutical business of Rubamin group, for an undisclosed amount.27 Sep, 2007, 12.15 PM IST
- Lupin picks up majority stake in SymbiotecAs part of its plan to expand in the steroids segment, pharmaceutical firm Lupin on Thursday said it has acquired a majority stake in Symbi...11 May, 2007, 03.07 AM IST
- Lupin joins hands with SymbiotecLupin on Thursday said it has made an equity investment in Symbiotec Pharmalab, a company focused on steroids, for a majority stake, in a b...10 May, 2007, 01.00 PM IST
- Govt to share Lupin's migraineThe government's Department of Science and Technology (DST) has committed over Rs 10 crore to support drug maker Lupin's two clinical devel...27 Apr, 2007, 12.20 PM IST
Load More
